2.89
2.03%
-0.06
시간 외 거래:
2.92
0.03
+1.04%
Sunshine Biopharma Inc (SBFM) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
1.81%
7.541
|
7.6802 | 5.9577 | 5.5609 | 4.8941 |
Cost Of Revenue |
1.46%
5.1867
|
5.1122 | 3.9674 | 3.6081 | 3.0659 |
Gross Profit |
8.32%
2.3543
|
2.568 | 1.9903 | 1.9527 | 1.8281 |
Operating Expenses
|
1.34%
3.7049
|
3.7553 | 2.7697 | 2.9424 | 3.6571 |
Interest Income/Expense |
63.34%
0.0492
|
0.0301 | 0.0385 | 0.0276 | 0.0411 |
Benefits Costs and Expenses |
1.06%
8.8025
|
8.71 | 6.5682 | 6.3753 | 6.5502 |
Costs And Expenses |
1.06%
8.8025
|
8.71 | 6.5682 | 6.3753 | 6.5502 |
Depreciation and Amortization |
0.63%
0.0426
|
0.0424 | 0.0372 | 0.0349 | 0.0347 |
Operating Income/Loss |
13.76%
-1.3506
|
-1.1872 | -0.7795 | -0.9896 | -1.829 |
Nonoperating Income/Loss |
43.39%
0.0891
|
0.1575 | 0.1689 | 0.1752 | 0.1728 |
Income/Loss From Continuing Operations Before Tax |
22.50%
-1.2614
|
-1.0298 | -0.6105 | -0.8144 | -1.6562 |
Income Tax Expense/Benefit |
89.85%
0.0224
|
0.2203 | 0.041 | 0.0877 | 0.0463 |
Income/Loss From Continuing Operations After Tax |
2.70%
-1.2838
|
-1.25 | -0.6515 | -0.9021 | -1.7024 |
Net Income/Loss
|
2.70%
-1.2838
|
-1.25 | -0.6515 | -0.9021 | -1.7024 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
466.02%
0.6413
|
-0.1752 | 25.69 | 25.35 | -1.5231 |
Diluted Average Shares |
466.02%
0.6413
|
-0.1752 | 25.69 | 25.35 | 22.04 |
Basic Earnings Per Share |
519.20%
-2.00
|
-0.323 | 0.04 | -0.02 | -0.07 |
Diluted Earnings Per Share |
-2.00
|
- | - | - | -0.08 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):